• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体裂解产物C3d作为系统性红斑狼疮疾病活动的指标。

Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus.

作者信息

Röther E, Lang B, Coldewey R, Hartung K, Peter H H

机构信息

Department of Rheumatology and Clinical Immunology, University of Freiburg Medical Center, Germany.

出版信息

Clin Rheumatol. 1993 Mar;12(1):31-5. doi: 10.1007/BF02231555.

DOI:10.1007/BF02231555
PMID:8467609
Abstract

In order to investigate, if complement levels can be used as an indicator of clinical activity in systemic lupus erythematosus (SLE), levels of C3, C4, CH50, and C3d were measured in 79 patients, 41 with inactive, 31 with moderately active and 7 with severely active disease. Our study shows that C3d, and particularly the C3d/C3 ratio, provide sensitive markers for disease activity in SLE. Since C3d is a direct measurement of complement turnover, it reflects complement activation better than C3, C4 and CH50.

摘要

为了研究补体水平是否可作为系统性红斑狼疮(SLE)临床活动的指标,我们对79例患者的C3、C4、CH50和C3d水平进行了检测,其中41例疾病不活动,31例中度活动,7例重度活动。我们的研究表明,C3d,尤其是C3d/C3比值,为SLE的疾病活动提供了敏感的标志物。由于C3d是补体转换的直接测量指标,它比C3、C4和CH50更能反映补体激活情况。

相似文献

1
Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus.补体裂解产物C3d作为系统性红斑狼疮疾病活动的指标。
Clin Rheumatol. 1993 Mar;12(1):31-5. doi: 10.1007/BF02231555.
2
Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.血浆和尿液补体裂解产物作为狼疮疾病活动指标的敏感性和特异性。
Arthritis Rheum. 1996 Jul;39(7):1178-88. doi: 10.1002/art.1780390716.
3
Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.系统性红斑狼疮中补体第四成分(C4)激活与疾病活动的相关性。
Ann Rheum Dis. 1988 Nov;47(11):913-7. doi: 10.1136/ard.47.11.913.
4
Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.红细胞C3d和C4d用于监测系统性红斑狼疮的疾病活动度。
Arthritis Rheum. 2010 Mar;62(3):837-44. doi: 10.1002/art.27267.
5
Serum complement abnormalities in the antinuclear antibody-positive relatives of children with systemic lupus erythematosus.系统性红斑狼疮患儿抗核抗体阳性亲属的血清补体异常
Arthritis Rheum. 1979 Sep;22(9):954-8. doi: 10.1002/art.1780220902.
6
Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.系统性红斑狼疮中抗核抗体、抗DNA抗体水平与补体之间的相关性
Acta Med Hung. 1988;45(2):145-59.
7
Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.补体片段 iC3b 血浓度与血清 C3 与系统性红斑狼疮疾病活动的相关性。
Arthritis Rheumatol. 2019 Mar;71(3):420-430. doi: 10.1002/art.40747. Epub 2019 Jan 24.
8
Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.尿新蝶呤作为系统性红斑狼疮患者疾病活动的一个参数:与血清可溶性白细胞介素-2受体、抗双链DNA抗体、红细胞沉降率以及血浆C3、C4和C3降解产物的比较
Ann Rheum Dis. 1993 Jun;52(6):429-35. doi: 10.1136/ard.52.6.429.
9
Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.红细胞上补体1型受体数量减少与抗心磷脂抗体水平升高有关。系统性红斑狼疮和抗磷脂综合征患者的研究结果。
Arthritis Rheum. 1989 Mar;32(3):259-64. doi: 10.1002/anr.1780320305.
10
The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis.将C3d用作监测系统性红斑狼疮和类风湿性关节炎临床活动的一种手段。
Ann Rheum Dis. 1983 Dec;42(6):668-71. doi: 10.1136/ard.42.6.668.

引用本文的文献

1
Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel.通过 FcγR 报告细胞小组检测和功能解析可溶性免疫复合物。
EMBO Mol Med. 2022 Jan 11;14(1):e14182. doi: 10.15252/emmm.202114182. Epub 2021 Nov 29.
2
Systemic complement activation levels in Stargardt disease.Stargardt 病患者的系统性补体激活水平。
PLoS One. 2021 Jun 25;16(6):e0253716. doi: 10.1371/journal.pone.0253716. eCollection 2021.
3
Complement Activation Levels Are Related to Disease Stage in AMD.补体激活水平与 AMD 的疾病阶段有关。

本文引用的文献

1
The C1q binding assay in systemic lupus erythematosus: discordance with disease activity.系统性红斑狼疮中的C1q结合试验:与疾病活动度不一致。
Arthritis Rheum. 1980 Nov;23(11):1282-6. doi: 10.1002/art.1780231109.
2
The 1982 revised criteria for the classification of systemic lupus erythematosus.1982年系统性红斑狼疮分类的修订标准。
Arthritis Rheum. 1982 Nov;25(11):1271-7. doi: 10.1002/art.1780251101.
3
Prognostic value of anti-dsDNA in SLE.抗双链DNA在系统性红斑狼疮中的预后价值。
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):18. doi: 10.1167/iovs.61.3.18.
4
The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus.补体 C3dg 片段优于常规 C3 作为系统性红斑狼疮的诊断生物标志物。
Front Immunol. 2018 Mar 26;9:581. doi: 10.3389/fimmu.2018.00581. eCollection 2018.
5
Systemic complement activation in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变中的全身补体激活
PLoS One. 2017 Jul 3;12(7):e0180312. doi: 10.1371/journal.pone.0180312. eCollection 2017.
6
Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis.补体受体 2 表达于神经祖细胞中,并调节成年海马神经发生。
J Neurosci. 2011 Mar 16;31(11):3981-9. doi: 10.1523/JNEUROSCI.3617-10.2011.
7
Occurrence of C-reactive protein in cryoglobulins.冷球蛋白中C反应蛋白的出现情况。
Clin Exp Immunol. 2001 Aug;125(2):316-22. doi: 10.1046/j.1365-2249.2001.01606.x.
8
Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.系统性红斑狼疮中枢神经系统受累的诊断与监测:F-18氟脱氧葡萄糖PET的价值
Ann Rheum Dis. 2000 May;59(5):377-85. doi: 10.1136/ard.59.5.377.
9
Antineutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis: a prospective study.类风湿关节炎中的抗中性粒细胞胞浆抗体(ANCA):一项前瞻性研究。
Rheumatol Int. 1996;15(6):231-7. doi: 10.1007/BF00290376.
10
Clinical utility of complement assessment.补体检测的临床应用
Clin Diagn Lab Immunol. 1995 Sep;2(5):509-17. doi: 10.1128/cdli.2.5.509-517.1995.
Ann Rheum Dis. 1982 Aug;41(4):388-95. doi: 10.1136/ard.41.4.388.
4
Useful laboratory measurements in the management of systemic lupus erythematosus.系统性红斑狼疮管理中的有用实验室检测指标。
Q J Med. 1982 Spring;51(202):125-38.
5
Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis.通过火箭免疫电泳法检测补体C3裂解产物C3d
J Immunol Methods. 1982;48(1):97-108. doi: 10.1016/0022-1759(82)90214-9.
6
Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.系统性红斑狼疮患者中C3d固定循环免疫复合物与疾病活动度及临床参数的相关性
Clin Exp Immunol. 1984 Mar;55(3):487-94.
7
The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis.将C3d用作监测系统性红斑狼疮和类风湿性关节炎临床活动的一种手段。
Ann Rheum Dis. 1983 Dec;42(6):668-71. doi: 10.1136/ard.42.6.668.
8
Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus.系统性红斑狼疮中的多种血清学反应及其与临床活动的关系。
Arthritis Rheum. 1984 Feb;27(2):132-8. doi: 10.1002/art.1780270203.
9
Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma.用于直接定量血浆中具有C3d特异性的补体C3裂解产物的双层火箭免疫电泳法。
J Immunol Methods. 1981;44(1):63-71. doi: 10.1016/0022-1759(81)90107-1.
10
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.低补体血症患者补体第三成分及富含甘氨酸的β糖蛋白的代谢研究。
J Clin Invest. 1974 Jun;53(6):1578-87. doi: 10.1172/JCI107708.